StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Ending Market Capitalization in USD by Quarter

Ending Market Capitalization in USD (USD million, converted from reported USD billion) ($M)

QuarterlyAnnual

Novartis Ending Market Capitalization in USD: $272,100M in Q3 2026, up 12.9% from a year earlier.

Latest, Q3 2026
272,100
Period ended Sep 30, 2026
Change on a year earlier
+12.9%
241,100 in Q3 2025
History
36 quarters
Since Q4 2017
Sources
29
Documents cited below

Where the Q3 2026 figure comes from

“|| Market capitalization (USD billions) 1 | 272.1 | 241.1”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEnding Market Capitalization in USD (USD million, converted from reported USD billion) ($M)Year on yearSource
Q3 2026Sep 30, 2026272,100+12.9%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 2026297,400+27.4%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026288,500+32.3%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 2025263,700+36.0%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 2025241,100+4.5%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 2025233,500+7.9%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 2025218,000+10.8%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 2024193,900-6.0%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 2024230,700+9.0%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 2024216,500+4.6%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 2024196,800-4.6%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 2023206,300+7.7%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 2023211,700+27.4%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 2023207,000+12.1%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 2023206,300+6.0%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 2022191,500-2.3%Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Ending Market Capitalization in USD ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/share-mcap-usd-b

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.